The weight-loss drug craze
FT News Briefing
00:00
Intro
This chapter explores major financial updates, including resistance in Britain to stricter corporate transparency and the effects of Moody's credit rating reductions on U.S. banks. It also examines the emerging weight loss drug market, projected to be worth $100 billion annually, and the implications for investors and the financial landscape.
Transcript
Play full episode
